MASLD and MASH: Clinical Spectrum and Modern Management, An Issue of Clinics in Liver Disease

Metabolic Dysfunction-Associated Steatotic Liver Disease: Global Epidemiology, Patient-Reported Outcomes, and Economic Impact<br>Association of Metabolic Dysfunction-Associated Steatohepatitis with Metabolic- Related Diseases: Diabetes, Prediabetes, and Obesity<br>Association of Metabolic Dysfunction-Associated Steatotic Liver Disease with Extrahepatic Cancers and Sarcopenia<br>Metabolic Liver Disease Beyond the Liver: Association of Metabolic Dysfunction- Associated Steatotic Liver Disease with Cardiovascular and Renal Diseases<br>Noninvasive Testing for Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis<br>Algorithms for Risk Stratification in Patients with Metabolic Dysfunction- Associated Steatohepatitis<br>Management of Metabolic Dysfunction-Associated Steatotic Liver Disease with Lifestyle Modification<br>Treatment of Modifiable Risks in Metabolic Dysfunction-Associated Steatotic Liver Disease: Drugs Targeting Obesity and Type 2 Diabetes<br>Currently Approved and Future Regimens for Metabolic Dysfunction-Associated Steatohepatitis<br>Special Populations: Hepatocellular Carcinoma Risk and Liver Transplantation<br>Special Population: Lean MASH<br>Special Population: A Global Perspective on Metabolic Dysfunction-Associated Alcohol-Related Liver Disease<br>What&rsquo;s New in Pediatric Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis<br>Metabolic Dysfunction-Associated Steatohepatitis in the Middle East: Clinical Challenges and Strategies to Bridge the Gap<br>Metabolic Dysfunction-Associated Steatotic Liver Disease in Asia: Epidemiology, Clinical Features, and Management<br>Metabolic Dysfunction-Associated Steatotic Liver Disease in Africa: From Burden to Action<br>Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America<br>Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Oceania, Central America, and the Caribbean<br>Metabolic Dysfunction-Associated Steatotic Liver Disease and Viral Hepatitis